Velcade Market

Velcade can be used in combination with mefalun and prednisone (MP) in previously untreated patients with multiple myeloma who are not suitable for high-dose chemotherapy and myelosuppression.Or single drug for multiple myeloma patients who have received at least one or more treatments and have relapsed;This product may be used in the treatment of patients with recurrent or refractory mantle cell lymphoma who have received at least one treatment prior to its use.

Velcade Market contains market size and forecasts of Velcade in global, including the following market information:

Global Velcade Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Velcade Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Velcade companies in 2021 (%)

The global Velcade market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

1.0 Mg Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Velcade include Johnson & Johnson, Takeda, Hospira, Ben Venue Laboratories, Xi'an Yangsen Pharmaceutical, XISUN, Wuhan Renfu Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical and Beijing Shuanglu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Velcade manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Velcade Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Velcade Market Segment Percentages, by Type, 2021 (%)

1.0 Mg Injection

3.5 Mg Injection

Global Velcade Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Velcade Market Segment Percentages, by Application, 2021 (%)

Multiple Myeloma

Mantle Cell Lymphoma

Global Velcade Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Velcade Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Velcade revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Velcade revenues share in global market, 2021 (%)

Key companies Velcade sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Velcade sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Johnson & Johnson

Takeda

Hospira

Ben Venue Laboratories

Xi'an Yangsen Pharmaceutical

XISUN

Wuhan Renfu Pharmaceutical

Nanjing Zhengda Tianqing Pharmaceutical

Beijing Shuanglu Pharmaceutical

Harbin Sanlian Pharmaceutical

Sinopharm Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Shanxi Pude Pharmaceutical

Guangdong Lingnan Pharmaceutical